rain cancer keeps popping up in the news for the wrong reasons. Last week, it took the life of Gord Downie, lead singer of the Canadian rock band The Tragically Hip. Sen. John McCain, who was diagnosed in July, recently acknowledged his prognosis is “very poor.”

But there are dozens of experimental therapies for glioblastoma in the works — and on Friday, the San Diego biotech company Tocagen (TOCA) reported some hopeful, though very early, news on one novel approach.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.